infection-congress-2018-scientifictracks-abstracts

14 / 18

Page 55
Notes:
conferenceseries.com
Volume 6 Journal of Infectious Diseases and Therapy
ISSN: 2332-0877 Infection Congress 2018
March 01-02, 2018
March 01-02, 2018 Berlin, Germany
5th International Congress on
INFECTIOUS DISEASES
Can herbal treatment be better than the leading drugs? A comparison of Gene-Eden-VIR/Novirin,
acyclovir and valacyclovir in oral herpes
Hanan Polansky, Adrian Javaherian and Edan Itzkovitz
Center for the Biology of Chronic Disease, USA
Background: Our previous papers showed that suppressive or preventive treatment with the herbal Gene-Eden-VIR/Novirin
reduced the number and duration of genital herpes outbreaks with no adverse effects. These studies also revealed that the
herbal Gene-Eden-VIR/Novirin is mostly superior to acyclovir, valacyclovir, and famciclovir drugs in genital herpes. This
study tested the effect of Gene-Eden-VIR/Novirin in oral herpes (also called cold sores and fever blisters).
Methods: The framework of the study was a retrospective chart review. The study included 68 participants. The participants
took 1-4 capsules per day over a period of 2-36 months. The study included two FDA recommended controls: baseline and a
no-treatment.
Results: Gene-Eden-VIR/Novirin was effective in 89.3% of participants. The treatment reduced the mean number of outbreaks
per year from 6.0 and 3.6 in the control groups to 2.0 in the treatment group (P<0.0001 and P=0.07, respectively). Gene-
Eden-VIR/Novirin reduced the mean duration of outbreaks from 9.8 and 5.8 days in the control groups to 3.2 days in the
treatment group (P<0.0001 and P=0.02, respectively). There were no reports of adverse experiences. Gene-Eden-VIR/Novirin
was compared to acyclovir and valacyclovir in six tests. In all tests, Gene-Eden-VIR/Novirin showed higher efficacy. Gene-
Eden-VIR/Novirin also showed superior safety.
Conclusions: This clinical study showed that suppressive or preventive treatment with the herbal Gene-Eden-VIR/Novirin
reduced the number and duration of outbreaks in oral herpes without any adverse effects. The study also showed that the
herbal Gene-Eden-VIR/Novirin had better clinical effects than acyclovir and valacyclovir, the leading drugs in the category.
Based on these results, we recommend using the herbal Gene-Eden-VIR/Novirin as preventive treatment for oral herpes, and
specifically, as an alternative to the acyclovir and valacyclovir drugs.
Biography
Hanan Polansky is the Director of the Center for the Biology of Chronic Disease (CBCD). He is also developer of Computer Intuition, a psycholinguistic-based data-
mining program that analyzes scientific text and assigns a rating to all ideas found in the text.
Hanan Polansky et al., J Infect Dis Ther 2018, Volume 6
DOI: 10.4172/2332-0877-C1-038